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ABSTRACT 
There is increasing evidence for rapid steroid action on electrolyte 
transport in human mononuclear leukocytes (HML). In HML, aldoste- 
rone stimulates the Na+/H+ antiporter within a few minutes. Because 
a variety of hormones and growth factors activate the Na+/H+ anti- 
porter via protein kinase C and inositol phospholipids, a possible 
involvement of inositol-1,4,5-trisphosphate (IP,) in the rapid effects of 
aldosterone in HML was investigated. 
The stimulation of IP3 generation was started by the addition of 
aldosterone, concanavalin A, or other steroids. A significant increase 
in IP3 levels by aldosterone (1 nmol/L, P < 0.05) was found after 1 
min, similar to that found after concanavalin A (25 rg/mL). Aldoste- 
rone caused a concentration-dependent elevation of IP3 levels, with an 
apparent ECso of approximately 0.1 nmol/L. Fludrocortisone stimu- 
lated IPB generation at similar concentrations, whereas a weaker IP3 
stimulation by glucocorticoids (hydrocortisone, dexamethasone) oc- 
curred at micromolar concentrations only. Canrenone, a potent inhib- 
itor of classical aldosterone action, was not effective up to a concentra- 
tion of 100 nmol/L. 
These findings show kinetic and pharmacological similarities with 
both the functional data on Na+/H+ antiport stimulation by aldosterone 
and the studies of Y-aldosterone binding to plasma membranes of 
HML. Thus, these data are the first to indicate an involvement of the 
phosphoinositide pathway in the rapid membrane effects of aldoste- 
rone. (J Clin Endocrinol Metab 77: 1452-1457,1993) 
I N THE CLASSICAL model of genomic steroid action, steroids bind to intracellular receptors which act as ligand- 
dependent transcription factors. The pathway of genomic 
steroid action involving transcription, translation, and pro- 
tein synthesis is characterized by late onset effects preceded 
by a latency of l-4 h. In contrast to these well known 
mechanisms, there is increasing evidence for rapid, probably 
nongenomic, steroid actions. These include neural effects by 
local application of steroids, fast effects of steroids on the y- 
aminobutyric acid* receptor, on LH-releasing peptide secre- 
tion, on dopamine release, and rapid effects of progesterone 
on the oocyte maturation and spermatozoan acrosome reac- 
tion (1). In vitro effects of aldosterone on intracellular elec- 
trolyte concentrations and cell volume have been demon- 
strated in human mononuclear leukocytes (HML) (2, 3) ini- 
tiated by a rapid stimulation of the sodium-proton antiport 
of the cell membrane (4). This stimulation has been shown 
to share close pharmacological and kinetic similarities with 
the radioactive binding of ‘251-labeled aldosterone to plasma 
membranes from HML (5). 
Although rapid increases of intracellular calcium in oocytes 
and spermatozoa after progesterone (6, 7) have been dem- 
onstrated, little is known about the involvement of other 
second messenger systems in fast steroid action. Changes of 
intracellular inositol-1,4,5-trisphosphate (lP3) levels occur- 
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ring in vascular smooth muscle cells (VSMC) 15 min after 
application of hydrocortisone (8), and the modulation of 
angiotensin II- and vasopressin-induced lP3 production in 
VSMC (9) after glucocorticoid treatment, indicate a possible 
involvement of the lP3 intracellular signaling system in rapid 
steroid action. In addition, in response to agents such as GH 
or angiotensin 11, the Na+/H+ antiport is stimulated via 
calcium and phospholipid-dependent pathways (10); there- 
fore, we investigated the potential role of lP3 generation on 
short-term effects of aldosterone. 
Materials and Methods 
Materials 
Aldosterone was purchased from Serva Feinbiochemica (Heidelberg, 
Germany), other steroids and sodium propionate from Sigma (St. Louis, 
MO). Canrenone was a gift of Dr. D. Armanini (University of Padua, 
Padua, Italy), and ethylisopropylamiloride (EIPA) was kindly provided 
by Dr. H. J. Lang (Hoechst AG, Frankfurt, Germany). Percoll was 
obtained from Pharmacia (Uppsala, Sweden), Fura-2-AM from Boehrin- 
ger Mannheim (Mannheim, Germany), thapsigargin and RPM1 1640 
medium from GIBCO Life Technologies (Berlin, Germany). All other 
reagents (analytical grade) were from Merck (Darmstadt, Germany). 
The IPa assay kit (TRK 1000) was purchased from Amersham Buchler 
(Braunschweig, Germany). 
Separation of HML 
The preparation of HML has already been described in detail else- 
where (3). Briefly, 150 mL peripheral blood from fasting healthy male 
volunteers (mean age f SD, 27.5 + 3.8 yr, range 21-34 yr) was drawn 
into heparinized syringes (Heparin Novo, Novo Industries, Germany) 
between 0800 and 0900 h. Informed consent was obtained in compliance 
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with the Declaration of Helsinki. The blood was centrifuged at 120 X g 
for 20 min. Platelet-rich plasma was removed, and the remaining pellet 
was mixed with 10% platelet-poor plasma. Mononuclear cells were 
separated by a Percoll gradient according to Hjorth et al. (11) and 
washed in RPM1 1640 medium. After another centrifugation at 120 X 
g, the preparation of human mononuclear cells contained 4-8% mono- 
cytes and 92-96% lymphocytes but no granulocytes and few platelets. 
Cell viability amounted to at least 95% before stimulation, as judged by 
trypan blue exclusion. 
Measurement of IPS in HML 
Levels of IP3 in HML were measured by a radioreceptor assay kit 
according to Sato et al. (9) and Palmer and Wakelam (12). HML were 
suspended in RPM1 1640 at a concentration of 6.8-7.5 X lo7 cells/ml. 
Addition of steroids and concanavalin A started the stimulation of IPa 
generation. Steroids were dissolved in ethanol in a 10 mmol/L stock 
solution. The reaction was stopped by 60 PL ice-cold 20% perchloric 
acid, and the mixture was kept on ice for 20 min. Centrifugation at 2000 
X g for 15 min at 4 C resulted in protein sedimentation. Supematants 
were kept on ice and titrated to pH 7.5 with 1.5 N KOH and 60 mmol/ 
L HEPES in siliconized tubes to minimize losses of phosphorylated 
inositol species, according to the method of Palmer et al. (13). After 
sedimentation of precipitated KCIOr, 100 PL supematant were mixed 
with equal amounts of assay buffer containing 0.1 mmol/L Tris/HCl, 4 
mmol/L ethylenediaminetetraacetic acid, and 4 mg/mL BSA (pH 9.0). 
D-M~o-[~H]IP~ (100 pL) and bovine adrenal binding protein were added 
and vortexed. After incubation for 15 min on ice, the protein-bound 
fraction was separated by centrifugation at 2000 x g for 15 minutes at 
4 C. The supematant was carefully decanted, and absorbent tissue was 
used to remove adhering liquid droplets in the tubes. The pellets were 
resuspended in 200 rL distilled water, and radioactivity was measured 
by ~-scintillation counting. The amount of IF’3 was calculated from a 
standard curve by plotting the percent B/B0 as a function of the log,0 of 
IPa standards. 
In this assay, the cross-reactivities of other inositolphosphates are 
less than 0.006% for inositol-l-phosphate, 0.02% for inositol-4-phos- 
phate, 0.015% for inositol-1,4-bisphosphate, 0.22% for inositol-1,3,4- 
trisphosphate, 1% for inositol-2,4,5-trisphosphate, and less than 1% for 
cyclic inositol-trisphosphate and inositol-1,3,4,5-tetrakisphosphate. 
Measurement of the activity of the Na’/H+ antiporter in HML 
The activity of the Na+/H+ antiporter in HML was determined by the 
time-dependent cell swelling in isotonic sodium propionate as described 
recently (4). HML were incubated in a buffer containing 140 mmol/L 
Na+ propionate, 1 mmol/L KCl, 1 mmol/L MgCl,, 1 mmol/L CaC12, 10 
mmol/L glucose, and 20 mmol/L HEF’ES, adjusted to a pH of 6.7. 
Aldosterone was added at concentrations indicated; maximum ethanol 
concentration in these experiments was 0.0001%. The cell diameters 
were determined by a Coulter Channelyzer 256 (Coulter Electronics, 
Luton, Great Britain). Plateau values of diameter after 30 min are 
considered as a measure of the initial activity of the sodium proton 
exchanger (14) and are used in the dose-response curve for this effect 
(see Fig. 2). 
Measurement of the free intracellular calcium concentration 
in HML 
Measurements of the free intracellular calcium concentration in HML 
were performed as described by Grynkiewicz et al. (15). Lymphocytes 
were incubated in 1 rmol/L Fura-2-acetoxymethylester at 37 C for 30 
min, washed, and resuspended in physiological buffer (140 mmol/L 
NaCl, 5 mmol/L KCl, 0.5 mmol/L MgCl,, 5 mmol/L glucose, 1 mmol/L 
NaZHPOr, and 10 mmol/L Tris/HCl, pH 7.4) in the presence or absence 
of external calcium (1 mmol/L). Changes in fluorescence of the Fura-2- 
loaded lymphocytes at the excitation wavelength of 340 and 380 nm 
and at the emission wavelength of 510 nm were measured. The ratios 
of maximum and minimum fluorescence were determined by the addi- 
tion of 250 pmol/L digitonin in the presence of 1 mmol/L free calcium 
and in the presence of 10 mmol/L EGTA (pH 2 8.5), respectively. 
Statistical analysis 
The two-tailed Wilcoxon test for paired data was used, including 
multiple comparison corrections according to the method of Bonferoni. 
Values of P < 0.05 were considered significant. The results were ex- 
pressed as mean f  SEM. Linear regression was calculated by least square 
analysis. 
Results 
Time course of the aldosterone-, hydrocortisone-, and 
concanavalin A-induced IP3 production 
The basal intracellular IP3 content of HML was 0.27 + 
0.02 pmol/106 cells. During incubation of HML in RPM1 
1640 with 0.01% ethanol (maximum vehicle concentration), 
a stable baseline of intracellular IP3 levels was obtained for 
up to 15 min. When HML were incubated with aldosterone, 
intracellular IP3 levels increased to a maximum of 0.58 + 
0.07 pmol/106 cells, or 239 + 33% of initial values after 60 s 
(n = 7; P < 0.05 US. initial values), and declined to 0.37 + 
0.03 pmol/106 cells (138 f 15%) after 5 min (P < 0.05). 
Intracellular IP3 levels were still significantly (P < 0.05) above 
baseline values after 15 min (0.39 f 0.05 pmol/106 cells; 145 
f 15%) (Fig. 1). IP3 levels after stimulation with concanavalin 
A were 0.53 f 0.05 pmol/106 cells (206 + 21%) after 60 s (n 
= 7; P < 0.05), being not significantly different from values 
60 s after aldosterone stimulation; however, after 5 and 15 
min of incubation with concanavalin A, IP3 levels were not 
different from baseline values. Intracellular IF’3 levels were 
slightly increased by 1 pmol/L hydrocortisone up to 0.37 + 
0.03 pmol/106 cells after 60 s (n = 4; 137 f 14%), which 
reached baseline values again after 5 and 15 min of incuba- 
tion. 
Effects of aldosterone on the Na+/H+ antiporter activity and 
IP3 production in HML 
A dose-related stimulation of the Na+/H+ antiporter (4) by 






FIG. 1. Time course of IPa stimulation in HML by aldosterone, con- 
canavalin A, and hydrocortisone is shown. HML were incubated in 
RPM1 1640 medium plus 0.01% ethanol (maximum vehicle concentra- 
tion during steroid stimulation) alone (CONTROL), with 25 pg/mL 
concanavalin A (CON A), with 1 nmol/L aldosterone (ALDO), or with 
1 rmol/L hydrocortisone (HYDRO) at room temperature. (*, P < 0.05 
for comparison with time 0 value; mean + SEM, n = 7; for hydrocorti- 
sone, n = 4). 
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in isotonic sodium propionate (Fig. 2) was found at half- 
maximal effects of approximately 0.1 nmol/L. Maximum 
increases of cell diameters after 30 min are shown as the 
differences of values obtained after incubation with and 
without 60 pmol/L EPA. 
The response of intracellular IP3 levels to aldosterone is 
shown in Fig. 2. There was a small effect on IP3 at an 
aldosterone concentration of 0.01 nmol/L, and near-maxi- 
mum IP3 levels were reached at a concentration of 10 nmol/ 
L. By increasing the concentration to 100 nmol/L, no further 
rise in IP3 values was obtained (not shown). Half-maximal 
effects (Et&) of aldosterone are seen at a concentration of 
approximately 0.1 nmol/L. Aldosterone increases intracellu- 
lar IP3 levels despite inhibition of the Na+/H+ exchanger by 
60 pmol/L EIPA (Fig. 3). After incubation with aldosterone 
in the presence of 60 pmol/L EPA, intracellular IP3 levels 
increased to 0.37 + 0.01 pmol/106 cells after 15 s and to 0.67 
f 0.03 pmol/106 cells after 60 s incubation; IP3 levels ob- 
tained with aldosterone alone were 0.36 + 0.02 and 0.51 + 
0.06 pmol/106 cells, respectively (n = 4). 
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FIG. 2. Top, Dose-response curve for maximum increases of HML 
diameter by aldosterone after an incubation for 30 min in isotonic Na+ 
propionate in excess of values obtained in the presence of 60 rmol/L 
EIPA (mean + SEM, n = 7-8). Bottom, Dose-response curve for aldo- 
sterone effects on IP3 in HML after an incubation for 1 min (mean + 
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FIG. 3. IPI levels in HML were measured after incubation in RPM1 
1640 medium alone (RPMI), with 1 nmol/L aldosterone (ALDO), and 
with 1 nmol/L aldosterone plus 60 rmol/L EIPA (ALDO + EIPA) for 
15 and 60 s (mean + SEM, n = 4). 
Effects of other steroids and canrenone on IP3 production 
in HML 
Fludrocortisone was active at concentrations between 0.01 
and 10 nmol/L (E& -0.1 nmol/L, Fig. 4). Near-maximum 
stimulation of IP3 was seen at 1 nmol/L, reaching absolute 
values similar to those after aldosterone stimulation. Hydro- 
cortisone did not stimulate II’3 generation up to a concentra- 
tion of 10 nmol/L. At 100 and 1000 nmol/L, a minor stim- 
ulation of IP3 was found; thus, the EC5,, is estimated to be 
about 1 pmol/L. Dexamethasone stimulates IP3 generation 
starting at about 100 nmol/L. Maximal IP3 levels at 1000 
nmol/L dexamethasone were not different from levels after 
stimulation with 1 nmol/L aldosterone. Incubation of the 
cells with 1 nmol/L aldosterone plus 100 nmol/L canrenone 
showed no significant inhibition of the aldosterone-induced 
IP3 response (Fig. 5), and canrenone (100 nmol/L) alone was 
inactive. 
Effects of aldosterone and thapsigargin on free intracellular 
calcium concentration in HML 
Within 5 min, aldosterone (l-100 nmol/L) and thapsigar- 
gin (0.5 pmol/L), a specific inhibitor of the Ca2+ ATPase in 
IP3-sensitive, intracellular calcium stores, do not significantly 
affect intracellular calcium concentrations in HML as deter- 
mined by Fura-2. Experiments were done with and without 
1 mmol/L Ca2+ in the incubation medium (not shown). 
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FIG. 4. Dose-response curve for IP, stimulation by fludrocortisone (F), 
hydrocortisone (C), and dexamethasone (D) in HML after an incuba- 
tion for 1 min. Experiments were done in triplicate, 
RPM ALDO ALDO+Can Can 
FIG. 5. IPB levels in HML were measured after incubation in RPM1 
1640 medium alone (RPMI), with 1 nmol/L aldosterone (ALDO), 1 
nmol/L aldosterone plus 100 nmol/L canrenone (Can), and 100 nmol/ 
L canrenone alone for 1 min. (*, P < 0.05; mean + SEM, n = 6). 
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Discussion 
An activation of the sodium-proton exchanger by aldoste- 
rone could be demonstrated in HML within 1-2 min (4), 
initiating the electrolyte and water shifts mentioned above. 
The time interval between aldosterone application and stim- 
ulation of the Na+/H+ antiport in HML is too short to reflect 
a genomic response. Actinomycin D, an inhibitor of tran- 
scriptional processes, was not able to block this effect. Thus, 
the rapid action of aldosterone was assumed to result from 
direct interaction with specific membrane receptors for al- 
dosterone that subsequently were demonstrated by binding 
studies (16) and characterized on sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (17). In the present study, 
the involvement of phosphoinositide hydrolysis as a possible 
second messenger system in these rapid aldosterone effects 
was investigated. 
The main findings of the present study may be summa- 
rized as follows: 1) In HML, aldosterone significantly stim- 
ulates the generation of IP3 within 60 s; 2) IP3 stimulation 
was concentration-dependent with an E& of approximately 
0.1 nmol/L, and inhibition of the Na+/H+ antiporter by the 
specific inhibitor EIPA was not able to antagonize these 
aldosterone effects; 3) fludrocortisone had similar effects, 
whereas hydrocortisone and dexamethasone were partially 
active with an E& of approximately 1 pmol/L; and 4) the 
classical mineralocorticoid inhibitor, canrenone, did not block 
aldosterone effects at 100-fold higher concentrations. 
Receptor-mediated hydrolysis of phosphatidylinositol-4,5- 
bisphosphate and generation of IP3 and diacylglycerol appear 
to play the key role for the activation of the Na+/H+ antiport 
by other hormones (10). Thus, a similar mechanism involving 
IP3 generation may be assumed for the rapid activation of 
the Na+/H+ exchanger by aldosterone in HML. The finding 
of an aldosterone selectivity of IP3 stimulation is in agreement 
with both the functional and membrane-binding data for 
aldosterone (4, 16) but is not compatible with the binding 
characteristics of the classical cloned type I mineralocorticoid 
receptor (18) that does not distinguish aldosterone from 
hydrocortisone. In addition, canrenone does not antagonize 
the aldosterone effect on IPJ stimulation, again consistent 
with data for aldosterone on Na+/H+ stimulation and mem- 
brane binding. To our knowledge, there is no agonist that 
could serve as a positive control for aldosterone effects 
selectively stimulating phospholipase C without a stimula- 
tion of other signalling systems in HML. This includes angio- 
tensin II, for which receptors are not found in HML (19). 
The pharmacological properties of the cloned type I min- 
eralocorticoid receptor (18), of aldosterone-related Na+/H+ 
and IP3 stimulation, and of aldosterone membrane binding 
are compared in Table 1. It is obvious that membrane recep- 
tors for aldosterone, but not the classical type I mineralocor- 
ticoid receptors, may be ideal candidates for the transmission 
of rapid aldosterone effects including the stimulation of IP3 
generation. Specific inhibition of the Na+/H+ exchanger by 
EIPA did not antagonize the aldosterone-induced changes of 
intracellular IP3 levels, thus ruling out a secondary increase 
of IP3 in response to the primary activation of the antiporter. 
Thus, it is concluded that IP3 may be a relevant second 
messenger in the intracellular signaling for the activation of 
the Na+/H+ exchanger by aldosterone. 
The linkage between the membrane receptor/aldosterone 
complex and stimulation of phospholipase C as a prerequisite 
of increased IP3 generation is still unclear. Orchinik et al. (20) 
suggested a possible involvement of guanine nucleotide- 
binding proteins in mediating agonist-receptor processes in 
steroid receptors of neuronal membranes. The binding of 
[3H]-corticosterone to amphibian neuronal membranes was 
inhibited by nonhydrolyzable guanyl nucleotides both in 
equilibrium saturation and in titration studies. The enhance- 
ment of inhibition by Mg*+ was consistent with the formation 
of a ternary complex of steroid, receptor, and guanine nu- 
cleotide regulatory protein. In the literature, steroid-induced 
breakdown of phosphoinositides was first reported in rat 
VSMC by Steiner et al. (8, 21). The maximum rate of IP3 
formation in VSMC treated by LiC& was up to lo-fold higher 
than basal levels at a concentration of about 6-9 pmol/L 
hydrocortisone after 15 min. RU 486, a potent antiglucocor- 
ticoid, inhibited hydrocortisone-induced response up to 50% 
(8). Glucocorticoid actions different from those depending 
on transcriptional and translational processes were postu- 
lated in that paper. For comparison with our data, it should 
be mentioned that a nonspecific inhibition of intracellular 
IP3 breakdown was obtained by LiC12 in the paper of Steiner 
et al. (S), thus augmenting increases of IP, levels; in addition, 
membrane receptors for mineralocorticoids may be occupied 
by glucocorticoids in concentrations higher than micromolar, 
and the effect of cortisol on IP3 may reflect an activation of 
the rapid aldosterone effector mechanism. 
With regard to the involvement of second messengers in 
rapid steroid action, it should be mentioned that steroid 
membrane receptors, rapid steroid effects, and related second 
messengers have been described earlier in other cells and for 
other steroids. The successful identification of high affinity 
steroid-binding sites in preparations of pituitary membranes 
(22), liver membranes (23, 24), and, recently, neuronal mem- 
branes (25) supports the hypothesis of nongenomic steroid 
action involving plasma membrane receptors different from 
TABLE 1. Comparison of properties of the cloned mineralocorticoid type I receptor (CMC),” of the membrane mineralocorticoid receptor 
(MMC), and of the functional results on rapid aldosterone (aldo) action on the Na+/H+ antiport in HML and IP3 generation 
CMC MMC Na+/H+ antiport IP3 generation 
Aldo required for dissociation constant (KJ/ECm (nmol/L) 1.4 -0.1 nmol/L -0.1 nmol/L -0.1 nmol/L 
Aldo/hydrocortisone selectivity -1:l -10,000:1 -10,000:1 -1,OOO:l 
Aldo/canrenone selectivity -5:l >l,OOo:l -10,000:1 >lOo:l 
Assumed location Cytosol/nucleus Plasma membrane Plasma membrane Plasma membrane 
’ See Ref. 18. 
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the classical intracellular steroid receptors. In addition, func- 
tional studies have shown rapid steroid effects on neurons 
(26), on neuronal LH-releasing peptide release (27), and on 
the acrosome reaction in spermatozoa (7). In terms of the 
second messengers involved in these rapid steroid effects, 
Sadler and Maller (28) have demonstrated that progesterone 
specifically inhibits adenylate cyclase in the Xenopus laevis 
oocyte plasma membrane. This effect appears to depend on 
a guanine nucleotide regulatory protein. These findings were 
consistent with experiments by Maller and Krebs (29) show- 
ing that the level of CAMP-dependent protein kinase activity 
is the critical factor for the regulation of oocyte meiotic cell 
division. Functional studies in oocytes, spermatozoa, and 
neurons identified early changes in the intracellular calcium 
concentration as a possible intracellular second messenger 
signal. Dufy et al. (30) observed an increased Ca’+-dependent 
spiking activity in pituitary cells after estradiol application. 
Progesterone-induced Ca*+ mobilization appears to be in- 
volved in meiotic maturation of the oocyte (6). Similar effects 
on intracellular Ca2+ concentration were found during acro- 
some reaction in spermatozoa (7). 
Concerning a possible involvement of calcium in rapid 
aldosterone effects on intracellular IP3 levels, the following 
findings in lymphocytes should be mentioned. Activation of 
lymphocytes by lectins such as concanavalin A or phytohe- 
magglutinin involves the stimulation of the phospholipase C 
turnover and concomitant increases of intracellular calcium 
due to the influx of extracellular calcium (31, 32). Grinstein 
et al. (33) demonstrated a concanavalin A-dependent stimu- 
lation of the Na+/H+ exchanger, which may be regulated by 
products of the phosphoinositide hydrolysis in thymic lym- 
phocytes but is not accompanied by an increase of intracel- 
lular Ca*+ in Ca*+ -free solution. In contrast to the small 
aldosterone effects found in HML so far (2, 3, 34), lectins 
drastically (and in part irreversibly) change lymphocyte func- 
tion on almost all cellular levels; this also involves the influx 
of extracellular calcium. Inasmuch as the increase of free 
intracellular calcium by IP3 appears to depend upon intra- 
cellular calcium stores only (35), the effects of thapsigargin, 
a specific inhibitor of Ca*+ ATPase of IP3-sensitive intracel- 
lular calcium stores (36), were investigated in HML. There 
was no significant increase of intracellular calcium in HML 
by thapsigargin in the presence and absence of extracellular 
calcium. This indicates that no significant intracellular cal- 
cium stores are present in HML; therefore, it is assumed that 
an intracellular liberation, but not an influx of extracellular 
calcium, may occur in response to aldosterone-stimulated 
increases of IPS. However, this intracellular liberation of 
calcium is not easily detectable in HML because these cells 
contain only few intracellular organelles, and the buffering 
capacity of the fluorescent dyes may obscure such minute 
changes. In earlier experiments, a minor increase of free 
intracellular calcium was observed in HML after incubation 
with aldosterone for 1 h (34). This late response probably 
involves a genomic component and thus may not be related 
to the fast effects on the Na+/H+ antiport and IP3 studied 
here. 
In conclusion, aldosterone selectively increases intracellu- 
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lar IP3 levels in HML with an apparent E& of about 0.1 
nmol/L, and hydrocortisone and dexamethasone are active 
only at much higher concentrations. These findings give 
additional support to the hypothesis of a novel rapid path- 
way for aldosterone action. Further intracellular signaling 
mechanisms such as the involvement of diacylglycerol and 
protein kinase C clearly need to be examined in terms of 
their relevance for these rapid, nongenomic aldosterone ef- 
fects. In addition, the physiological significance of HML 
plasma membrane receptors and the related rapid effects on 
electrolyte transport for immune responses or cell differen- 
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